|
| 37787745 | Evaluation of Malignant Hyperthermia Features in Patients with Pathogenic or Likely Pathogenic RYR1 Variants Disclosed through a Population Genomic Screening Program. | Anesthesiology | 2024 |
| 36602781 | Thyroidectomy Outcomes in Patients Identified With RET Pathogenic Variants Through a Population Genomic Screening Program. | JAMA Otolaryngol Head Neck Surg | 2023 |
| 37542411 | Low adenoma burden in unselected patients with a pathogenic APC variant. | Genet Med | 2023 |
| 37870835 | Testing and Management of Iron Overload After Genetic Screening-Identified Hemochromatosis. | JAMA Netw Open | 2023 |
| 37308598 | Defining critical educational components of informed consent for genetic testing: views of US-based genetic counselors and medical geneticists. | Eur J Hum Genet | 2023 |
| 35216901 | The reckoning: The return of genomic results to 1444 participants across the eMERGE3 Network. | Genet Med | 2022 |
| 35341655 | ClinGen's Pediatric Actionability Working Group: Clinical actionability of secondary findings from genome-scale sequencing in children and adolescents. | Genet Med | 2022 |
| 35668420 | Observational study of population genomic screening for variants associated with endocrine tumor syndromes in a large, healthcare-based cohort. | BMC Med | 2022 |
| 35363504 | Establishing the Medical Actionability of Genomic Variants. | Annu Rev Genomics Hum Genet | 2022 |
| 35692820 | A RE-AIM Framework Analysis of DNA-Based Population Screening: Using Implementation Science to Translate Research Into Practice in a Healthcare System. | Front Genet | 2022 |
| 36474257 | Implementation-effectiveness trial of systematic family health history based risk assessment and impact on clinical disease prevention and surveillance activities. | BMC Health Serv Res | 2022 |
| 36556164 | Investigating Psychological Impact after Receiving Genetic Risk Results-A Survey of Participants in a Population Genomic Screening Program. | J Pers Med | 2022 |
| 36143296 | Understanding the Patient Experience of Receiving Clinically Actionable Genetic Results from the MyCode Community Health Initiative, a Population-Based Genomic Screening Initiative. | J Pers Med | 2022 |
| 35128484 | Clinical validation of genomic functional screen data: Analysis of observed <i>BRCA1</i> variants in an unselected population cohort. | HGG Adv | 2022 |
| 32782180 | Uncertainty management for individuals with Lynch Syndrome: Identifying and responding to healthcare barriers. | Patient Educ Couns | 2021 |
| 33684294 | Clinical Findings and Diagnostic Yield of Arrhythmogenic Cardiomyopathy Through Genomic Screening of Pathogenic or Likely Pathogenic Desmosome Gene Variants. | Circ Genom Precis Med | 2021 |
| 33683017 | Balancing External Validity and Concern for Psychosocial Harms in Translational Genetic Research. | Ethics Hum Res | 2021 |
| 33786929 | Genetic counseling for patients with positive genomic screening results: Considerations for when the genetic test comes first. | J Genet Couns | 2021 |
| 33926532 | Application of a framework to guide genetic testing communication across clinical indications. | Genome Med | 2021 |
| 34945775 | Defining the Critical Components of Informed Consent for Genetic Testing. | J Pers Med | 2021 |
| 34646007 | Correction to: Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants. | Genet Med | 2021 |
| 34377931 | Penetrance of Breast Cancer Susceptibility Genes From the eMERGE III Network. | JNCI Cancer Spectr | 2021 |
| 33480803 | Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis: Identification Methods, Patient Activation, and Cascade Testing for Familial Hypercholesterolemia. | Circ Genom Precis Med | 2021 |
| 32345712 | Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention. | Science | 2020 |
| 32028596 | Healthcare Utilization and Costs after Receiving a Positive <i>BRCA1/2</i> Result from a Genomic Screening Program. | J Pers Med | 2020 |
| 32092541 | Design and Reporting Considerations for Genetic Screening Tests. | J Mol Diagn | 2020 |
| 33160339 | At the intersection of precision medicine and population health: an implementation-effectiveness study of family health history based systematic risk assessment in primary care. | BMC Health Serv Res | 2020 |
| 32601386 | Clinical outcomes of a genomic screening program for actionable genetic conditions. | Genet Med | 2020 |
| 32414353 | Pediatric reporting of genomic results study (PROGRESS): a mixed-methods, longitudinal, observational cohort study protocol to explore disclosure of actionable adult- and pediatric-onset genomic variants to minors and their parents. | BMC Pediatr | 2020 |
| 32413979 | Understanding the Return of Genomic Sequencing Results Process: Content Review of Participant Summary Letters in the eMERGE Research Network. | J Pers Med | 2020 |
| 32350418 | Positive impact of genetic counseling assistants on genetic counseling efficiency, patient volume, and cost in a cancer genetics clinic. | Genet Med | 2020 |
| 30693090 | Preferences of women with epithelial ovarian cancer for aspects of genetic testing. | Gynecol Oncol Res Pract | 2019 |
| 29875427 | Implementation, adoption, and utility of family health history risk assessment in diverse care settings: evaluating implementation processes and impact with an implementation framework. | Genet Med | 2019 |
| 29976988 | Developing a conceptual, reproducible, rubric-based approach to consent and result disclosure for genetic testing by clinicians with minimal genetics background. | Genet Med | 2019 |
| 30866001 | Effect of Sociodemographic Factors on Uptake of a Patient-Facing Information Technology Family Health History Risk Assessment Platform. | Appl Clin Inform | 2019 |
| 29261187 | Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants. | Genet Med | 2018 |
| 30100086 | A Model for Genome-First Care: Returning Secondary Genomic Findings to Participants and Their Healthcare Providers in a Large Research Cohort. | Am J Hum Genet | 2018 |
| 30311382 | Evidence-based assessments of clinical actionability in the context of secondary findings: Updates from ClinGen's Actionability Working Group. | Hum Mutat | 2018 |
| 30646163 | Exome Sequencing-Based Screening for BRCA1/2 Expected Pathogenic Variants Among Adult Biobank Participants. | JAMA Netw Open | 2018 |
| 29385584 | Parental attitudes and expectations towards receiving genomic test results in healthy children. | Transl Behav Med | 2018 |
| 29733722 | Patient-Centered Precision Health In A Learning Health Care System: Geisinger's Genomic Medicine Experience. | Health Aff (Millwood) | 2018 |
| 27265406 | Adherence to Recommended Risk Management among Unaffected Women with a BRCA Mutation. | J Genet Couns | 2017 |
| 28434142 | Cancer Genetic Counseling and Testing in an Era of Rapid Change. | J Genet Couns | 2017 |
| 28596016 | Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper. | Gynecol Oncol | 2017 |
| 28552198 | Evaluating the Clinical Validity of Gene-Disease Associations: An Evidence-Based Framework Developed by the Clinical Genome Resource. | Am J Hum Genet | 2017 |
| 28045615 | Cost Comparison of Genetic Testing Strategies in Women With Epithelial Ovarian Cancer. | J Oncol Pract | 2017 |
| 25070967 | Randomized trial of DVD, telephone, and usual care for increasing mammography adherence. | J Health Psychol | 2016 |
| 27124788 | A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variation. | Genet Med | 2016 |
| 27242960 | Alternate Service Delivery Models in Cancer Genetic Counseling: A Mini-Review. | Front Oncol | 2016 |
| 26938783 | Clinical utility of a Web-enabled risk-assessment and clinical decision support program. | Genet Med | 2016 |